ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 996,64
0,49%
Dow Jones
38 718,08
0,11%
DAX
18 175,21
1,01%
Brent Oil
83,385
0,31%
Bitcoin
63 541,77
-0,71%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Opko Health Inc (OPK)

  7. Opko Health Inc (OPK) Actualités

OPK Opko Health Inc

1,315
0,015 (1,15%)
Dernière mise à jour : 17:36:27
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Opko Health Inc OPK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,015 1,15% 1,315 17:36:27
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,29 1,29 1,32 1,30
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202414:00GLOBEOPKO Health to Report First Quarter 2024 Financial Results..
28/3/202413:00PRNUSLabcorp Announces Acquisition of Select Assets of..
20/3/202413:00GLOBEEntera Bio Announces Robust Pharmacokinetic Data for..
07/3/202422:02EDGAR2Form ARS - Annual Report to Security Holders
05/3/202414:52GLOBEAIDS Clinical Trial Group Presents Results from Phase 1..
01/3/202422:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
28/2/202415:31PRNUSNextPlat Opens OPKO Health-Branded Storefront on Alibaba's..
27/2/202422:07EDGAR2Form 8-K - Current report
27/2/202422:05GLOBEOPKO Health Reports Fourth Quarter 2023 Business Highlights..
22/2/202422:05GLOBEOPKO Health to Report Fourth Quarter 2023 Financial Results..
16/2/202422:53EDGAR2Form PRE 14A - Other preliminary proxy statements
09/2/202422:07EDGAR2Form 8-K - Current report
05/2/202414:09PRNUSNextPlat Receives Initial Approvals to Launch OPKO..
29/1/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:00EDGAR2Form 8-K - Current report
17/1/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:09EDGAR2Form 8-K - Current report
09/1/202422:05GLOBEOPKO Health Announces Closing of Private Offering of $230..
08/1/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:00GLOBEOPKO Health to Present at the 42nd Annual J.P. Morgan..
05/1/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202413:00EDGAR2Form 8-K - Current report
05/1/202405:31GLOBEOPKO Health Announces Pricing of Private Offering of $200..
03/1/202423:05GLOBEOPKO Health Announces Private Offering of Convertible Senior..
28/11/202313:00PRNUSBioReference Health and Prognos Health Collaborate to..
13/11/202314:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202314:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202312:45PRNUSBioReference® Signs On as the First Laboratory to Use..
06/11/202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:06EDGAR2Form 8-K - Current report
06/11/202322:05GLOBEOPKO Health Reports Third Quarter 2023 Business Highlights..
02/11/202315:00GLOBENew Clinical Data on OPKO Health’s RAYALDEE® (ER..
31/10/202321:08EDGAR2Form 8-K/A - Current report: [Amend]
31/10/202313:00GLOBEOPKO Health to Report Third Quarter 2023 Financial Results..
25/10/202322:25GLOBEOPKO Health to Present New Clinical Data on Rayaldee (ER..
28/9/202323:10DJNModeX Therapeutics Awarded Contract to Address Public Health..
28/9/202322:09EDGAR2Form 8-K - Current report
28/9/202322:08GLOBEModeX Therapeutics Secures BARDA Contract to Develop Novel..
12/9/202314:30GLOBEEntera Bio Announces Collaboration with OPKO Biologics to..
03/8/202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:07EDGAR2Form 8-K - Current report
03/8/202322:05GLOBEOPKO Health Reports Second Quarter 2023 Business Highlights..
25/7/202322:05GLOBEOPKO Health to Report Second Quarter 2023 Financial Results..
30/6/202322:10EDGAR2Form 8-K - Current report
28/6/202312:45BWFDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly..

Dernières Valeurs Consultées

NASDAQ
OPK
Opko Health
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés